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ABSTRACT A total of 216 Brown Dwarf laying hens
(1.62 ± 0.06 kg BW and 60 wk old) were fed 1 of 3 corn-
soybean meal-based diets containing 0, 2.5, or 5.0% conju-
gated linoleic aicd (CLA) to explore its effects on the fatty
acid composition of egg yolk, plasma, and liver as well
as hepatic stearoyl-coenzyme A desaturase-1 (SCD-1) ac-
tivity and its mRNA gene expression. Four hens were
placed in wired-ﬂoored cages (45 × 40 × 45 cm) and 3
cages were grouped as 1replicate, resulting in 6 replicates
per treatment. The experimental diets were fed for 54 d,
and then eggs were collected to determine the fatty acid
composition of egg yolk. Four eggs were randomly se-
lected from the total day’s production for each replicate,
and the contents were pooled prior to analysis. On d 56,
one randomly chosen hen from each replicate (6 hens per
replicate and a total of 18 hens) was bled via heart punc-
ture and then killed in order to collect liver samples to
(Key words: conjugated linoleic acid, laying hen, stearoyl-coenzyme A desaturase, mRNA expression)
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INTRODUCTION
Conjugated linoleic acid (CLA) refers to a mixture of
positional and geometric isomers of linoleic acid (Ha et
al., 1987). Consumption of CLA by humans has been
reported to elicit many favorable health beneﬁts, such
as modulating immune function, reducing weight, and
providing protection against diseases such as cancer and
arteriosclerosis (Chin et al., 1992; Lee et al., 1994; Nicolosi
etal.,1997).Somenegativeeffectsalsohavebeenreported
as it has been observed that the trans-10,cis-12 isomer of
CLA increased insulin resistance and glycemia while also
reducing high-density lipoprotein cholesterol levels in
humans (Riserus et al., 2002).
Ithasbeenpredictedthata70-kghumanmustconsume
approximately 1.5 to 3.0 g/d of CLA in order to obtain
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measure the fattyacid proﬁle of plasma andliver tissue as
well as hepatic SCD-1 activity and its mRNA abundance.
Dietary supplementation of CLA resulted in a signiﬁcant
deposition of CLA in egg yolk, plasma, and liver lipids
(P < 0.01). As the dietary level of CLA increased, the
concentration of saturated fatty acids in egg yolk, plasma,
and liver also increased (P < 0.05). However, the concen-
tration of monounsaturated fatty acids in these same tis-
sues decreased (P < 0.01). Compared with the control, the
activity of SCD-1 was reduced by feeding 2.5% CLA (P <
0.05) without a change in SCD-1 mRNA gene expression.
However, feeding 5% CLA reduced both SCD-1 activity
and mRNA abundance (P < 0.05). These results indicate
thatthe conversionof saturatedto monounsaturatedfatty
acids in egg yolk, plasma, and liver might be modulated
directly at hepatic mRNA gene expression levels, or may
be indirectly regulated at the downstream post-transcrip-
tional levels.
any potential health beneﬁts (de Deckere, 1995). This
amount of CLA is signiﬁcantly greater than the estimated
0.5 to 1.0 g/d of CLA currently consumed in the US
and other countries (Ip et al., 1991). As a result, there is
considerable interest in supplementing animal feeds with
CLA in order to increase the CLA content of animal prod-
ucts destined for human consumption.
Eggs from CLA-fed chickens are a good source of CLA
in the human diet (Chamruspollert and Sell, 1999; Du et
al., 1999; Raes et al., 2002; Shang et al., 2004). However,
Du et al. (1999) reported that dietary CLA increased the
concentration of saturated fatty acids (SFA) and de-
creased the concentration of monounsaturated fatty acids
(MUFA) in the egg yolk, which is consistent with other
reports (Ahn et al., 1999; Raes et al., 2002; Shang et al.,
2004).Thepotentialregulatingmechanismthroughwhich
Abbreviation Key:CLA = conjugated linoleic acid; SCD-1 = stearoyl-
coenzymeAdesaturase-1; SFA=saturatedfattyacid;MUFA=monoun-
saturated fatty acid.
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dietary CLA affects the fatty acid content of egg yolk has
not been determined.
Park et al. (2000) reported that mouse hepatic stearoyl-
coenzyme A desaturase-1 (SCD-1) activity was signiﬁ-
cantlyinhibitedbytrans-10,cis-12CLAanditsderivatives.
Choi et al. (2000) reported that treating differentiating
3T3-L1 preadipocytes of mice with trans-10,cis-12 CLA
resulted in a dose-dependent decrease in the expression
of the SCD-1 gene. As SCD-1 catalyses the insertion of a
double bond between carbons 9 and 10 in both C16:0 and
C18:0 fatty acids (Cook, 1991), and the liver is the key
organ of lipid metabolism for poultry, we hypothesized
that dietary CLA might inhibit SCD-1 activity and the
expression of the hepatic SCD-1 gene, decreasing the
amount of SFA converted into MUFA, and changing the
relative concentrations of SFA and MUFA in the tissue
of laying hens. To test this hypothesis, the current experi-
ment was designed to determine the impact of increasing
levels of CLA in the diet of laying hens on the fatty acid
proﬁle of liver, plasma, and egg yolk, as well as its effects
on hepatic SCD-1 activity and its mRNA gene expression.
The data obtained in the current study were obtained as
part of a larger study examining the effects of CLA on
laying hen productivity and cholesterol metabolism in
eggs (X. G. Shang, unpublished data).
MATERIALS AND METHODS
Dietary Treatments
Three corn-soybean meal-based diets were formulated
using 0, 3.85, and 7.70% of a lipid source that contained
65% CLA, resulting in diets providing 0, 2.5, or 5.0%
actual CLA (Table 1). The CLA2 contained 43.2% cis-
9,trans-11, 40.3% trans-10,cis-12, 5.2% cis-11,trans-13, 1.6%
cis-9,cis-11,2.0%cis-10,cis-12,and7.6%trans-9,trans-11po-
sitional isomers of CLA. To equalize the concentration of
total fat in all diets, the CLA source was substituted for
soybean oil on an equal weight basis. To avoid fat oxida-
tion, diets were prepared fresh each week, and an antioxi-
dant (0.04% ethoxyquin3) was added to all diets. The legal
inclusion limit for ethoxyquin in the US is 0.015%, but
there is no upper inclusion limit for ethoxyquin in China.
The experiment diets were formulated to provide 2,941
kcal of ME/kg, 0.98% total lysine, 0.45% total methionine,
3.78% calcium, and 0.38% available phosphorus. A vita-
min-mineral premix4 was added so that all dietary treat-
ments met or slightly exceeded the nutrient requirements
recommended by the Ministry of Agriculture of China
(2002). The composition of the diets is presented in Ta-
ble 1.
2Aohai Co., Qingdao, Shangdong Province, People’s Republic of
China.
3Shanghai San Wei Feed Additive Co., Beijing, People’s Republic
of China.
4Debao Company, Haidian District, Beijing, People’s Republic of
China.
5College of Animal Science and Technology, China Agricultural Uni-
versity, Haidan District, Beijing, People’s Republic of China.
Table 1. Ingredient composition of diets fed to laying hens (% as-
fed basis)
Level of dietary conjugated
linoleic acid, %
Ingredients 0 2.5 5.0
Corn 41.66 41.66 41.66
Soybean meal 34.00 34.00 34.00
Wheat bran 5.00 5.00 5.00
Soy oil 7.70 3.85 0.00
Conjugated linoleic acid1 0.00 3.85 7.70
Limestone 9.00 9.00 9.00
Dicalcium phosphate 1.20 1.20 1.20
Salt 0.37 0.37 0.37
Vitamin-mineral premix2 1.00 1.00 1.00
Methionine 0.07 0.07 0.07
1Supplied by Aohai Co., Qingdao, People’s Republic of China. The
CLA source contained 65.0% CLA, which consisted of 43.2% cis-9,trans-
11; 40.3% trans-10,cis-12; 5.2% cis-11,trans-13; 1.6% cis-9,cis-11; 2.0% cis-
10,cis-12; and 7.6% trans-9,trans-11 positional isomers.
2Premix provided per kilogram of diet: iron, 70 mg; copper, 7 mg;
zinc, 70 mg; manganese, 70 mg; selenium 0.36 mg; retinyl acetate, 8,000
IU; cholecalciferol, 2,750 IU; dl-α-tocopheryl acetate, 15 IU; thiamine,
1.5 mg; riboﬂavin, 4.0 mg; vitamin B6, 2.9 mg; vitamin B12,1 0g; niacin,
25 mg; pantothenic acid, 10 mg; folic acid, 0.38 mg; biotin, 50 mg;
choline, 400 mg.
Bird Management
A total of 216 Brown Dwarf5 laying hens (1.62 ± 0.06
kg of BW and 60 wk old) were used in the study. The
birds were housed 4 to a cage, in wired-ﬂoored cages
measuring 45 × 40 cm, and with a height of 45 cm. Three
cages were grouped as 1replicate, resulting in 6 replicates
per treatment. Feed and water were provided ad libitum.
The photoperiod was set at 17L:7D throughout the 56 d
experiment. The room temperature was maintained at 25
± 5°C.
Feed Analysis
Feed samples from each diet were taken after mixing
and stored at 4°C until analysis. The diets were analyzed
for CP by Kjeldahl methodology (N × 6.25, AOAC, 1999).
Total lipids in diets were determined by the method of
Folchetal.(1957),andthefattyacidcompositionoftissues
was analyzed as described below. The CP, total lipid,
and fatty acid composition of the diets are presented in
Table 2.
Preparing of Egg Yolks, Plasma,
and Liver Samples
After feeding the experimental diets for 54 d, eggs were
collected to determine the fatty acid composition of the
egg yolk. Four eggs were randomly selected from the
total day’s production from each replicate (total 24 eggs
per treatment), the eggs were broken open and the con-
tents were pooled prior to analysis (6 replicates per
treatment).
On d 56, one randomly chosen hen from each replicate
(6 hens per replicate and a total of 18 hens) was bled via
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 SHANG ET AL. 1888
Table 2. The crude protein, total lipid, and fatty acid composition of
diets (% as-fed basis) containing different concentrations of conjugated
linoleic acid (CLA2)
Levels of dietary conjugated
linolenic acid, %
Item 0 2.5 5.0
Chemical analysis
Crude protein 19.78 19.47 19.90
Total lipids 10.27 10.18 10.24
Fatty acid proﬁle
Palmitic acid 1.35 1.03 0.87
Stearic acid 0.38 0.32 0.29
Oleic acid 1.98 1.36 1.38
Linoleic acid 5.27 3.62 2.05
Linolenic acid 0.82 0.52 0.23
Conjugated linoleic acid 0.05 2.41 4.93
1Shown as the percentage of methyl ester of each fatty acid.
2The CLA source contained 65.0% CLA, which consisted of 43.2% cis-
9,trans-11; 40.3% trans-10,cis-12; 5.2% cis-11,trans-13; 1.6% cis-9,cis-11;
2.0% cis-10,cis-12; and 7.6% trans-9,trans-11 positional isomers.
heart puncture using 9 mL of heparinized Vacutainer
tubes.6 The blood samples were centrifuged at 1,500 × g
for 10 min, and then the plasma was removed and stored
at −20°C in order to determine the fatty acid proﬁle of
plasma.
Thebirdswere thenkilledbyconventional neckcutting
and the body cavity was excised in order to collect liver
samples to measure the fatty acid proﬁle of the liver as
well as hepatic SCD-1 activity and its mRNA abundance.
Immediately after the hens were killed, a 4-g sample of
liver was homogenized with a polytron grinder7 in 16
mL of0.25Msaccharoseand 0.05 Mphosphate potassium
buffer solution(pH 7.4). Thehomogenate wasthen centri-
fuged for 30 min at 10,000 × g. The supernatant was
recoveredwithapipetteanditsproteincontentwasdeter-
mined on a Technicon RA-1000 biochemical analyzer8
using reagents obtained from a commercially available
kit.9Another4-g sampleofliverwassnap-frozen inliquid
nitrogen and stored at −70°C for total RNA extraction.
Fatty Acid Analysis and SCD-1
Enzyme Activity Measurement
Fatty acid analysis was carried out according to the
method described by Raes et al. (2002). The fatty acid
6Vacuette; Greiner Bio-One Co., Minato-Ku, Tokyo, Japan.
7Taisite Machine Limited Corp., Tianjin City, People’s Republic of
China.
8Bayer Diagnostic Manufacturing Ltd., Dublin, Ireland.
9Zhongsheng Beikong Bio-Technology and Science Co., Beijing, Peo-
ple’s Republic of China.
10Hewlett-Packard Co., Wilmington, DE.
11Varian Co., Palo Alto, CA.
12Sigma Chemical Co., St Louis, MO.
13Matreya Biochemicals, State College, PA.
14Invitrogen Life Technologies, Carlsbad, CA.
15Promega, Madison, WI.
16Shanghai Bio-engineering Co., Shanghai, People’s Republic of
China.
17Tianwie Corp., Beijing, People’s Republic of China.
18Biological Engineer Corp., Shanghai, People’s Republic of China.
Table 3. Primer sequence of stearoyl-coenzyme A desaturase-1 (SCD1)
and β-actin (house-keeping gene)
Primer Primer sequence Position and length
SCD1 F TGG CTA CCG TGT CCC TGT C 212–497
SCD1 R GTC CGT CCC ACC TCC CTT CT 287 bp
β-Actin F TTC CTG GGT ATG GAA TCC TG 113–596
β-Actin R CAC CTT CAC CGT TCC AGT TT 485 bp
methylesterswereanalyzedbygaschromatographywith
a Hewlett-Packard HP6890gas chromatography System10
installed with a Chrompack capillary column11 (CP–Sil
88 column; 100 m × 250 m × 0.25 m). The gas chroma-
tography conditions were as follows: 250°C injector tem-
perature; 250°C detector temperature; He carrier gas; 1:40
split ratio; temperature program set for 180°C for 45 min,
followed by an increase of 10°C/min to 215°C, and then
maintained for 17 min. Heptadecanoic acid (C17:0) was
added as an internal standard. Peaks were identiﬁed by
comparison of retention times with those of the corres-
ponding standards from Sigma Co.12 and Matreya Bio-
chemicals.13 Identiﬁcation of the peaks included fatty
acids between C14:0 and C24:1 and the 6 CLA isomers
knowntobeinthesamplebasedoninformationprovided
bythemanufacturer.Trans-8,cis-10CLAisomerwasprob-
ably present in the CLA source, but its peak overlapped
with that of cis-9,trans-11 CLA and could not be detected.
The hepatic SCD-1 activity was analyzed according to
the method described by Legrand et al. (1987). The en-
zyme activity was expressed as nanomoles of stearic acid
converted to oleic acidmin−1g of liver sample−1.
Total RNA Isolation
and Reverse Transcription
Hepatic total RNA was extracted from each liver sam-
ple with TRIzol reagent14 according to the manufacturer’s
recommendations. After extraction, 2 g of total RNA
was reverse-transcribed using 2.0 L of random hexamer
primer,15 2.0 L of dNTP,12 0.8 L of RNasin inhibitor,16
2.0 L of M-MLV transcriptase,14 and 23.2 L of RNase-
free water.14
Generation of cDNA for Real-Time
PCR Calibration Curves
According to the sequence of the gene published in
GenBank (Lefevre et al., 2001; Morgan and Burnside,
2002), primers for SCD and β-actin gene (housekeeping
gene) were chosen with Primer Express Software16 (Table
3). Two microliters of the reverse transcription product
was ampliﬁed for 35 cycles in a 20-L reaction system
containing 10.0 L of PCR reaction kit17 and 0.5 mMol/
L of each forward and reverse primer.18 The ampliﬁcation
conditions for SCD and β-Actin gene were conducted
using denaturation at 94°C for 1 min, annealing at 59.3°C
for 30 s, and primer extension at 72°C for 30 s. After ﬁnal
extension at 72°C for 8 min, the integrity of the linear
double-stranded cDNA was veriﬁed by ethidium bro-
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Table4.Inﬂuenceofdietaryconjugatedlinoleicacid(CLA)concentrationsonfattyacidcompositionofyolklipids
Dietary CLA concentration, %
Fatty acid proﬁle, % 0 2.5 5.0 SEM P-value
Myristic 0.31a 0.54b 0.66c 0.04 <0.01
Palmitic 24.31a 28.20b 30.52b 0.91 <0.01
Palmitoleic 0.60b 0.31a 0.8a 0.03 <0.01
Steric 12.45a 15.33b 16.29b 0.60 <0.01
Oleic 28.20c 18.37b 15.96a 0.70 <0.01
Linoleic 28.43c 23.02b 14.95a 0.56 <0.01
Linolenic 1.62c 1.37b 0.64a 0.04 <0.01
Cis-9,trans-11 CLA 0.00a 5.70b 9.96c 0.35 <0.01
Cis-11,trans-13 CLA 0.00a 0.60b 0.98c 0.04 <0.01
Trans-10,cis-12 CLA 0.00a 2.69b 5.42c 0.13 <0.01
Cis-9,cis-11 CLA 0.00a 0.19b 0.34c 0.02 <0.01
Cis-10,cis-12 CLA 0.00a 0.10b 0.25c 0.01 <0.01
Trans-9,trans-11 CLA 0.00a 1.05b 1.81c 0.07 <0.01
Total CLA 0.00a 10.33b 18.76c 0.66 <0.01
Arachidonic 2.11c 1.18b 0.82a 0.05 <0.01
Nervonic 1.10c 0.33b 0.15a 0.04 <0.01
Total saturated fatty acids 37.07a 44.08b 47.48b 1.34 <0.01
Total monounsaturated fatty acids 30.01c 19.12b 16.51a 0.75 <0.01
Total polyunsaturated fatty acids 32.53a 36.20b 35.43b 0.89 0.04
a,b,cMeans within a row without a common superscript are different (P < 0.05).
mide staining and plating on agarose gel. Primer se-
quences, the position in the coding region, and the ex-
pected PCR product length are summarized in Table 3.
Tenfold serial dilutions of SCD and β-Actin gene PCR
products from 106 down to 10 copies per well were pre-
pared for real-time PCR calibration curves.
Real-Time PCR
The quantiﬁcation of all gene transcripts was carried
out by real-time PCR. A 20-L reaction system was pre-
pared containing 10 L of DyNAmo SYBR Green qPCR
Mix,15 1 L of forward primer (0.5 mol/L), 1 Lo f
reverse primer (0.5 mol/L), and 6.0 L of water. The
PCR protocol conducted on a DNA Engine Option 2 ﬂuo-
rescence detection system19 included uracil-DNA glyco-
sylase incubation at 50°C for 2 min, and initial denatur-
ation at 95°C for 5 min, followed by 40 cycles of 94°C
for 1 min, 59°C for 30 s, and 72°C for 30 s. Real-time
quantiﬁcation was monitored by measuring the increase
in ﬂuorescence caused by the binding of SYBR (MJ Re-
search, BioRad Laboratories, Hercules, CA) green dye to
double-stranded DNA at the end of each ampliﬁcation
cycle.
At the end of the PCR, dissociation was performed by
slowly heating the samples from 60 to 95°C and continu-
ous recording of the decrease in SYBR green ﬂuorescence
resulting from the dissociation of double-stranded DNA.
The threshold cycle, deﬁned as the cycle at which an
increase in ﬂuorescence above a deﬁned baseline could
ﬁrst be detected, was determined for each sample. The
SCD and β-actin gene mRNA levels were determined
19MJ Research, Inc., Waltham, MA.
20Applied Biosystems, Chaoyang District, Beijing, People’s Republic
of China.
from the threshold cycle plotted on the respective stan-
dard curves. The results were expressed as the SCD
mRNA/β-actingenemRNAratio.EachPCRrunincluded
a blank, reverse-transcribed cDNA, and calibration curve
dilution samples. Runs were performed in triplicate. In
addition, product identity was conﬁrmed by sequencing.
The PCR products were puriﬁed using DNA Wizard
cleanup kit15 and directly sequenced by Taq cycle using
DyeDeoxy terminators15 in an automated sequencer.20
Statistical Analysis
All the data were subjected to one-way ANOVA proce-
dures using the GLM model procedure of the SAS pro-
gram (SAS Institute, 1996). Fisher’s protected least sig-
niﬁcant difference test was used to determine differences
between treatment means. A level of P < 0.05 was used
as the criterion for statistical signiﬁcance.
Figure 1. Effects of dietary conjugated linoleic acid (CLA) concentra-
tion on the activity of stearoyl-coenzyme A desaturase-1 (SCD-1).
a–cMeans without a common letter are different (P < 0.05).
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 SHANG ET AL. 1890
Table 5. Inﬂuence of dietary conjugated linoleic acid (CLA) concentrations on fatty acid composition of
plasma lipids
Dietary CLA concentration, %
Fatty acid proﬁle, % 0 2.5 5.0 SEM P-value
Myristic 0.24a 0.27b 0.30c 0.01 <0.01
Palmitic 24.82a 26.88b 27.50b 0.35 <0.01
Palmitoleic 0.62b 0.39a 0.32a 0.05 <0.01
Steric 10.60a 15.37b 16.63b 0.86 <0.01
Oleic 29.81c 24.39b 20.55a 1.13 <0.01
Linoleic 27.07c 21.14b 18.18a 0.89 <0.01
Linolenic 1.19c 0.67b 0.46a 0.06 <0.01
Cis-9,trans-11 CLA 0.00a 3.66b 7.85c 0.25 <0.01
Cis-11,trans-13 CLA 0.00a 0.34b 0.69c 0.03 <0.01
Trans-10,cis-12 CLA 0.00a 1.12b 2.55c 0.11 <0.01
Cis-9,cis-11 CLA 0.00a 0.15b 0.33c 0.02 <0.01
Cis-10,cis-12 CLA 0.00a 0.07b 0.17c 0.01 <0.01
Trans-9,trans-11 ClA 0.00a 0.40b 0.93c 0.05 <0.01
Total CLA 0.00a 5.74b 12.52c 0.69 <0.01
Arachidonic 3.04b 2.95b 2.03a 0.24 0.02
Nervonic 1.85c 1.34b 0.51a 0.14 <0.01
Total saturated fatty acids 35.67a 42.53b 44.44b 0.74 <0.01
Total monounsaturated fatty acids 32.41c 27.23b 23.52a 1.12 <0.01
Total polyunsaturated fatty acids 31.72 29.97 31.53 1.89 0.56
a,b,cMeans within a row without a common superscript are different (P < 0.05).
RESULTS AND DISCUSSION
Effects of Dietary CLA on Fatty Acid Proﬁle
Dietary inclusion of CLA resulted in signiﬁcant in-
creases in the CLA content of egg yolk, plasma, and liver
(P < 0.01) (Tables 4, 5, and 6), which was consistent with
other reports (Ahn et al., 1999; Shang et al., 2004). All
fatty acids measured in egg yolk were altered (P < 0.01)
by dietary supplementation with CLA (Table 4). With an
increase in dietary CLA, the concentrations of myristic,
palmitic, and stearic acids were signiﬁcantly increased
(P < 0.01), whereas the concentrations of oleic, linoleic,
linolenic, and arachidonic acids in egg yolk lipids were
signiﬁcantly decreased (P < 0.01). The total SFA and poly-
Table 6. Effects of dietary conjugated linoleic acid (CLA) concentrations on fatty acid composition of liver lipids
Dietary CLA concentration, %
Fatty acid proﬁle, % 0 2.5 5.0 SEM P-value
Myristic 0.15a 0.18b 0.21c 0.01 0.02
Palmitic 22.07 21.91 22.16 0.34 0.25
Palmitoleic 0.27b 0.19ab 0.15a 0.04 0.04
Steric 24.44a 24.10a 26.10b 0.51 0.05
Oleic 18.21c 17.07b 14.21a 0.30 <0.01
Linoleic 19.01 18.28 18.53 0.53 0.49
Linolenic 0.39b 0.23a 0.24a 0.03 0.02
Cis-9,trans-11 CLA 0.00a 4.59b 4.08b 0.28 <0.01
Cis-11,trans-13 CLA 0.00a 0.36b 0.40b 0.03 <0.01
Trans-10,cis-12 CLA 0.00a 1.78b 1.80b 0.11 <0.01
Cis-9,cis-11 CLA 0.00a 0.15b 0.14b 0.01 <0.01
Cis-10,cis-12 CLA 0.00a 0.02b 0.03b 0.01 <0.01
Trans-9,trans-11 CLA 0.00a 0.25b 0.24b 0.04 <0.01
Total conjugated linoleic acid 0.00a 7.15b 6.69b 0.42 <0.01
Arachidonic 9.50b 7.01a 7.42a 0.20 <0.01
Nervonic 4.02b 1.55a 1.28a 0.27 <0.01
Total saturated fatty acids 46.66a 46.20a 48.46b 0.40 0.03
Total monounsaturated fatty acids 23.22c 19.61b 16.58a 0.58 <0.01
Polyunsaturated fatty acids 29.87a 33.63b 34.02b 0.42 <0.01
a,b,cMeans within a row without a common superscript are different (P < 0.05).
unsaturated fatty acid composition were signiﬁcantly in-
creased (P < 0.01) and the content of MUFA were signiﬁ-
cantly reduced (P < 0.01) with dietary CLA supplemen-
tation.
The effect of dietary CLA on the fatty acid composition
of egg yolks has been extensively studied. Ahn et al.
(1999) found that the concentration of SFA increased,
whereas MUFA tended to decrease in yolk lipids of hens
fed CLA compared with hens fed a control diet without
CLA. Other researchers have reported ﬁndings similar to
those observed in the current study (Schafer et al., 2001;
Yang et al., 2002; Cherian et al., 2002; Szymczyk and
Pisulewski, 2003, Shang et al., 2004). However, there are
very few reports on the effects of dietary CLA on the fatty
acid proﬁle of plasma and liver in laying hens. Similar to
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Figure 2. Effects of dietary conjugated linoleic acid (CLA) concentra-
tion on the expression of mRNA for stearoyl-coenzyme A desaturase-
1(SCD-1)gene. a–cMeanswithoutacommonletteraredifferent(P<0.05).
what was observed in egg yolk, as CLA in the diet in-
creased, the concentration of SFA in plasma and liver
also signiﬁcantly increased (P < 0.03), accompanied by a
signiﬁcant decrease in MUFA concentration (P < 0.01)
(Table 5 and 6).
Liver is the key organ of lipid metabolism. After lipo-
genesis in the liver, fatty acids are transported via the
bloodcirculationsystemmainlybyvery-lowdensitylipo-
proteins to supply the requirement of fat tissue and the
ovary (Wang et al., 2002). Therefore, the fatty acid proﬁles
of egg yolks are dependent on those of the liver and
plasma. The similar nature of the changes in fatty acid
concentration in yolk, plasma and liver indicate that he-
patic lipid metabolism was changed by dietary CLA.
Effects of Dietary CLA on SCD-1 Activity
The conversion of stearoyl–coenzyme A to oleyl-coen-
zyme A in animal tissues, and particularly in avian liver
is catalyzed by SCD-1 (Wang et al., 2002). This enzyme
has been studied mostly with the rat. The results of the
current experiment demonstrated that with increasing
concentration of dietary CLA, the hepatic SCD-1 activity
was signiﬁcantly decreased (Figure 1), which was consis-
tent with results observed in mice (Lee et al., 1998; Bretil-
lon et al., 1999; Choi et al., 2001). Similar results also were
observed in the adipose tissue of ﬁnishing pigs fed 1.5%
CLA (Smith et al., 2002). These results indicate that the
activity of SCD-1 could be inhibited by CLA in these
different animal species. Park et al. (2000) reported that
trans-10,cis-12 CLA had a strong inhibitory activity on
SCD-1, whereas cis-9,trans-11, and trans-9,trans-11 iso-
mers had no effect, implying a cis-12 double bond of
CLA might be a key structural feature for inhibiting SCD-
1 activity.
Effects of Dietary CLA on mRNA
Abundance of SCD-1 Gene
The mechanism of dietary CLA decreasing hepatic
SCD-1 activity in laying hens remains obscure. In this
research, we found that the mRNA abundance of SCD-1
gene was decreased by feeding 5% CLA (P < 0.05) com-
pared with the control group. However, no signiﬁcant
difference was observed by feeding 2.5% CLA (Figure 2).
This result is consistent with the report of Choi et al.
(2000), who found that treating the differentiating 3T3-
L1 preadipocytes of mice with trans-10,cis-12 isomers of
CLA resulted in a dose-dependent decrease in the gene
expression of SCD-1. A similar result also was observed
in vivo by Lee et al. (1998). However, Choi et al. (2001)
reported that there was no change in the SCD-1 gene
transcription, mRNA, and protein levels of human hepa-
toblastoma cell lines treated with the trans-10,cis-12 CLA
isomer. In the current study, compared with the control,
the activity of SCD-1 was signiﬁcantly decreased by feed-
ing 2.5% CLA without a change in SCD-1 mRNA gene
expression. However, 5% CLA reduced both the SCD-1
activity and mRNA abundance.
The overall results of this study conﬁrm earlier studies
showing that increasing CLA in the diet of laying hens
increases the CLA concentration of egg yolk. The experi-
ment also showed that the CLA content of plasma and
liver were also increased. As the CLA level in the diet
increased, the concentration of SFA in egg yolk, plasma
and liver were increased accompanied by a signiﬁcant
decrease in MUFA. The inhibition of SFA desaturation
to MUFA might be modulated directly at the hepatic
mRNA gene expression levels or indirectly regulated at
the downstream post-transcriptional levels.
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